In the early stages of tumorigenesis, CD8+ T cells are effectively activated by the PD-1 antibody, however, in the late-stage tumor immune microenvironment, dysfunction of tumor-specific CD8+ T cells may inevitably become irreversible [15, 16]. The gene discussed is PDCD1; the disease is neoplasm.